Rossari Biotech's MD Sunil Chari On Q1 And How Weak Raw Material Prices Impacted Growth

Rossari Biotech's MD Sunil Chari shares his thought on company's performance on Business Today TV with Shail Bhatnagar and Sakshi Batra. He lists out company's plans for FY24 and how weak material prices hit its earnings.